These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1300731)

  • 21. [T cell depletion for allogeneic bone marrow transplantation].
    Morishima Y
    Nihon Rinsho; 1990 Sep; 48(9):1971-6. PubMed ID: 2232199
    [No Abstract]   [Full Text] [Related]  

  • 22. Xenophobia, T cells and a journey to a foreign land.
    Gale RP; Butturini A
    Thymus; 1990 Aug; 16(1):1-5. PubMed ID: 2219230
    [No Abstract]   [Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 24. T-cell depletion and allogeneic bone marrow transplantation.
    O'Reilly RJ
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
    [No Abstract]   [Full Text] [Related]  

  • 25. Characteristics and functions of inflammatory cells isolated from acute graft-versus-host disease target organs after bone marrow transplantation in the rat.
    Renkonen R; Leszczynski D; Wangel A; Häyry P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2689. PubMed ID: 3274579
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunobiology of bone marrow transplantation as treatment for hematologic malignancies.
    Champlin R
    Transplant Proc; 1991 Aug; 23(4):2123-7. PubMed ID: 1871828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 29. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of donor bone marrow cells that abrogate second-set allograft rejection.
    Pourshadi M; De Fazio SR; Gozzo JJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):479-80. PubMed ID: 8438386
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow transplantation for leukemia: effects of T lymphocyte depletion of donor bone marrow.
    Champlin R
    Transplant Proc; 1987 Feb; 19(1 Pt 1):157-9. PubMed ID: 3274769
    [No Abstract]   [Full Text] [Related]  

  • 34. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance to engraftment in irradiated dogs receiving T cell-depleted bone marrow transplants.
    Bradstock KF; Prendergast MM; Hughes WG; Broomhead AF; Kabral A; Tiver K
    Transplant Proc; 1987 Apr; 19(2):2902-6. PubMed ID: 3551233
    [No Abstract]   [Full Text] [Related]  

  • 38. Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: the potential role of IL-2.
    Sykes M
    Bone Marrow Transplant; 1992; 10 Suppl 1():1-4. PubMed ID: 1521080
    [No Abstract]   [Full Text] [Related]  

  • 39. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
    Soiffer RJ; Mauch P; Tarbell NJ; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Murrey CI; Coral F; Bosserman L
    Bone Marrow Transplant; 1991 Jan; 7(1):23-33. PubMed ID: 2043874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell depletion in allogeneic bone marrow transplantation: progress and problems.
    Marmont AM; Gale RP; Butturini A; Goldman JM; Martelli MF; Prentice HG; Slavin S; Storb R; Truitt RL; Van Bekkum DW
    Haematologica; 1989; 74(3):235-48. PubMed ID: 2511092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.